| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |